Article

timesofisrael.com on 2022-02-09 02:47

Pfizer sees COVID-19 vaccine, therapeutic sales topping $50 billion in 2022

Chief Executive Albert Bourla says 2021 was a 'watershed year' for drugmaker, with its efforts during the pandemic 'fundamentally changed our company ...

Related news

Pfizer CEO Sees Annual Covid Vaccine Rather Than Frequent Boosters longislandpress.com
Israel , New York , Germany , Maintal
Pfizer vaccine approved for children aged 12 to 15 years by Therapeutic Goods Administration Sydney Morning Herald
United Kingdom , Israel , United States , Australia , Australia
Pfizer, BioNTech begin Omicron vaccine trial timesofisrael.com
China , Greece , Thessaloniki , Israel , United States
EU agrees to potential 1.8 billion-dose purchase of Pfizer vaccine The Day
Europe , Germany , Americas , Belgium , Puers
U.S. Signs $2 Billion Vaccine Deal with Pfizer and BioNTech infowars.com
Germany , United States
White House announces US$2 billion Pfizer contract for vaccine Sydney Morning Herald
New York , Europe , United States , Germany
HPfizer CEO Sees Annual COVID Vaccine Rather Than Frequent Boosters hamodia.com
Israel
TPfizer CEO sees annual COVID vaccine rather than frequent boosters torontosun.com
Israel
Pfizer expects $26 billion in 2021 sales from COVID vaccine New York Post
Michigan
Pfizer CEO: We’re working on COVID vaccine against Omicron timesofisrael.com
Jerusalem , Germany , Israel , South Africa , Greece
Pfizer CEO questions whether 4th dose of COVID vaccine needed timesofisrael.com
United States , Chile , Greece , Thessaloniki , Jerusalem
Pfizer seeking FDA approval for COVID-19 vaccine booster dose timesofisrael.com
Germany , Jerusalem , United States , Israel
Pfizer sees strong demand for COVID pill as profits surge timesofisrael.com
Israel , United States , Greece , Thessaloniki , New York
Pfizer says three doses of its COVID vaccine protect against Omicron timesofisrael.com
United States , South Africa , Greece , Thessaloniki , Israel
Pfizer hikes 2021 outlook after vaccine boosts sales, profit timesofisrael.com
Tel Aviv , Tel Aviv-Yafo , Tate Modern , United States , Europe
Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year’s End The New York Times
Massachusetts , United Arab Emirates , China , Europe , United States
Pfizer reports final vaccine results: 95% efficacy Ars Technica
Argentina , Brazil , South Africa , Turkey , United States
EU seals deal for an extra 1.8 billion BioNTech/Pfizer vaccine doses timesofmalta.com
Malta , Mexico , Europe , United States , Germany
US government and Pfizer reach $1.95 billion deal to produce millions of Covid-19 vaccine doses CNN
Phase 1 , United States